Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 133
Filter
Add more filters

Publication year range
1.
Blood Cells Mol Dis ; 54(3): 224-30, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25703683

ABSTRACT

BACKGROUND: Fetal hemoglobin (HbF) levels in sickle cell anemia patients vary. We genotyped polymorphisms in the erythroid-specific enhancer of BCL11A to see if they might account for the very high HbF associated with the Arab-Indian (AI) haplotype and Benin haplotype of sickle cell anemia. METHODS AND RESULTS: Six BCL112A enhancer SNPs and their haplotypes were studied in Saudi Arabs from the Eastern Province and Indian patients with AI haplotype (HbF ~20%), African Americans (HbF ~7%), and Saudi Arabs from the Southwestern Province (HbF ~12%). Four SNPs (rs1427407, rs6706648, rs6738440, and rs7606173) and their haplotypes were consistently associated with HbF levels. The distributions of haplotypes differ in the 3 cohorts but not their genetic effects: the haplotype TCAG was associated with the lowest HbF level and the haplotype GTAC was associated with the highest HbF level and differences in HbF levels between carriers of these haplotypes in all cohorts were approximately 6%. CONCLUSIONS: Common HbF BCL11A enhancer haplotypes in patients with African origin and AI sickle cell anemia have similar effects on HbF but they do not explain their differences in HbF.


Subject(s)
Anemia, Sickle Cell/genetics , Carrier Proteins/genetics , Fetal Hemoglobin/genetics , Nuclear Proteins/genetics , Polymorphism, Single Nucleotide , Adolescent , Adult , Black or African American/genetics , Arabs/genetics , Asian People/genetics , Child , Female , Genotype , Haplotypes , Humans , Male , Middle Aged , Repressor Proteins , Young Adult
2.
J Biol Regul Homeost Agents ; 26(3): 327-35, 2012.
Article in English | MEDLINE | ID: mdl-23034252

ABSTRACT

The aim of this study is to test the activity of a marine bioactive compound containing high-purity caviar-derived DNA, collagen elastin and protein extracts from sturgeon (LD-1227, Caviarlieri, Laboratoires Dom, Switzerland) to exert neuroprotective properties in an experimental setting while also being potential triggers of neurogenesis in a separate in vitro study. Supplementation with high-DHA mixture of LD-1227 was applied for 30 days to stress model rats. Both supplementations significantly mitigated the histological brain damage when analyzing hippocampal subregions and corticosterone level. However, LD-1227 was most significantly efficient in preventing SOD, Catalase and ascorbic acid decrease in brain tissue. Both supplementations stimulated neurogenesis in vitro and neuron markers in particular but og olygodendrocyte markers and glia increased only in LD-1227-enriched medium. Taken together, these data suggest that LD-1227 is able to significantly protect the brain structure redox system to higher degree than DHA. Moreover, from in vitro study it appears that marine bioactive compound, through it wide array of small unsaturated fatty acids, phospholipids and neurotransmitter precursors, is likely to influence neuronal and glial lineage to act differently from a DHA-rich mixture.


Subject(s)
Complex Mixtures/pharmacology , Fish Proteins/pharmacology , Fishes , Hippocampus/metabolism , Neurodegenerative Diseases/drug therapy , Neurogenesis/drug effects , Animals , Antigens, Differentiation/metabolism , Cells, Cultured , Complex Mixtures/chemistry , Fish Proteins/chemistry , Hippocampus/pathology , Neurodegenerative Diseases/metabolism , Neurodegenerative Diseases/pathology , Rats , Rats, Sprague-Dawley
3.
Nat Med ; 5(5): 560-4, 1999 May.
Article in English | MEDLINE | ID: mdl-10229234

ABSTRACT

Familial Alzheimer disease mutations of presenilin 1 (PS-1) enhance the generation of A beta1-42, indicating that PS-1 is involved in amyloidogenesis. However, PS-1 transgenic mice have failed to show amyloid plaques in their brains. Because PS-1 mutations facilitate apoptotic neuronal death in vitro, we did careful quantitative studies in PS-1 transgenic mice and found that neurodegeneration was significantly accelerated in mice older than 13 months (aged mice) with familial Alzheimer disease mutant PS-1, without amyloid plaque formation. However, there were significantly more neurons containing intracellularly deposited A beta42 in aged mutant transgenic mice. Our data indicate that the pathogenic role of the PS-1 mutation is upstream of the amyloid cascade.


Subject(s)
Alzheimer Disease/genetics , Alzheimer Disease/pathology , Membrane Proteins/genetics , Neurons/pathology , Plaque, Amyloid , Age Factors , Amyloid beta-Peptides/isolation & purification , Animals , Apoptosis , Cell Count , Humans , Mice , Mice, Transgenic , Mutation, Missense , Peptide Fragments/isolation & purification , Presenilin-1
4.
J Biol Regul Homeost Agents ; 25(1): 37-45, 2011.
Article in English | MEDLINE | ID: mdl-21382272

ABSTRACT

The aim of this study is to gain further insights into the possible nutraceutical effect on redox balance via thioredoxin (Trx) modulation and on the intrinsic susceptibility of monocytes to generate an inflammatory response. The study group consisted of thirty-two patients with compensated Child A-C, HCV-related cirrhosis. The patients were supplemented for 6 months with 6g/day of a certified fermented papaya preparation (FPP). Fifteen unsupplemented, age/gender-matched healthy subjects served as controls. The patients filled in a detailed diet-life style questionnaire, and blood samples were collected to test routine biochemistry, Trx, redox status (GSH, GSSG, GSH/GSSG ratio, 4-HNE and alpha-tocopherol). Moreover, isolated monocytes were tested for ex-vivo LPS-stimulated TNF-alpha production and TNF-alpha mRNA. As compared to control, patients with liver cirrhosis showed a significantly higher serum level of Trx. A significant correlation occurred with GSH/GSSG ratio in Child B and C patients. FPP supplementation brought about a significant reduction of Trx with levels comparable to the ones of healthy controls. Ten patients Child C (31.2 percent) showed borderline low levels of alpha-tocopherol while all cirrhotic patients, as a whole, showed a significantly abnormal redox balance. Supplementation with FPP did not modify alpha-tocopherol depletion but significantly improved redox balance parameters. Patients with liver cirrhosis showed a significantly upregulated TNF-alpha production in a time-dependent manner and this effect was more pronounced in more advanced stages of the disease and showed a significant correlation with alpha-tocopherol level. Supplementation with FPP significantly, although partially, downregulated TNF-alpha production from monocytes. Taken altogether, it would appear that the typical oxidative-inflammatory biochemical milieu of these patients is mirrored by a significant TNF-alpha upregulation at a monocyte level while a targeted nutraceutical might be a potentially amenable intervention to be part of validated scheduled treatments.


Subject(s)
Antioxidants/administration & dosage , Carica , Dietary Supplements , Liver Cirrhosis/blood , Signal Transduction/drug effects , Thioredoxins/blood , Tumor Necrosis Factor-alpha/blood , Aged , Female , Glutathione/blood , Hepatitis B/blood , Hepatitis C/blood , Humans , Male , Middle Aged , Monocytes/metabolism , Oxidation-Reduction/drug effects , Time Factors , Up-Regulation/drug effects , alpha-Tocopherol/blood
5.
J Biol Regul Homeost Agents ; 25(3): 341-9, 2011.
Article in English | MEDLINE | ID: mdl-22023758

ABSTRACT

This study aims to determine the effects of different alkaline supplementations on high protein diet-induced abnormalities affecting bone metabolism in rats which were also undergoing physical exercise of moderate intensity. Sixty elderly Sprague-Dawley rats were randomly divided into four groups of 10 rats each and treated for 16 weeks as follows: baseline control group fed normal food (C); acidic high-protein diet supplemented group (chronic acidosis, CA group), bicarbonate-based alkaline formula (Basenpulver, Named, Italy) supplemented chronic acidosis (BB-CA) and citrate-based alkaline supplement (CB-CA). Throughout the supplementation period, rats were put on a treadmill training mimicking a moderate level of exercise. In the CA group, 24-hour urinary calcium (Ca) and phosphorus (P) excretion were increased over 30 percent (p<0.05 vs normal diet controls). However serum Ca was not significantly changed. Femural and tibial BMD and BMC was significantly decreased in the CA group (p<0.05) but both alkaline supplementations prevented such phenomenon (p<0.05 vs CA), without significant difference between the two formulations although the BB-CA group showed significantly more preserved trabecular bone volume (p<0.05 vs CB-CA group). An increased level of over 50 percent of urinary Dpd observed in the CA group (p<0.001) was reverted to normal by both supplementations (p<0.001 vs CA group). The same applied to urinary net acid excretion (p<001) with BB-supplementation performing better than CB-supplementation (p<0.05). Moreover, while the latter did not modify Nterminal telopeptide value, BB-supplementation significantly normalized this parameter (p<0.05 vs CA group) which exercise and acidic protein diet had modified (p<0.01 vs control diet). Overall, the present study shows that a bicarbonate-based alkaline formula, when administered to a dose amenable to clinical use, may significantly protect bone structure in exercising aged animals to a greater extent than a quali/quantitavely similar citrate-based formula.


Subject(s)
Acidosis/blood , Acidosis/urine , Aging , Bicarbonates/pharmacology , Bone and Bones/metabolism , Calcium/blood , Calcium/urine , Citrates/pharmacology , Dietary Supplements , Phosphorus , Physical Conditioning, Animal , Acidosis/etiology , Alkalies/pharmacology , Animals , Chronic Disease , Dietary Proteins/pharmacology , Male , Phosphorus/blood , Phosphorus/urine , Rats , Rats, Sprague-Dawley
6.
J Biol Regul Homeost Agents ; 25(2): 187-94, 2011.
Article in English | MEDLINE | ID: mdl-21880207

ABSTRACT

The main object of this study is to examine the effect of Klamin®, a nutraceutical containing phenylethylamine, phycocyanins, mycosporine-like aminoacids and aphanizomenon flos aquae-phytochrome on the learning and memory ability, the oxidative status and cerebral erythropoietin and its receptor EPO/EPOR system in prematurely senescent (PS) mice. A total of 28 PS mice, selected according to a prior T-maze test, and 26 non-prematurely senescent mice (NPS) mice were chosen. PS animals were divided into 3 groups and followed for 4 weeks: A) normal chow diet; B) added with Klamin® at 20 mg/kg/day (low dose); C) added with Klamin® at 100mg/kg/day (high dose). A further group of NPS mice given either normal food (group D) or high dose Klamin® (group E) was also considered. The behavioral procedures of spatial learning ability (Morris test) showed that PS mice had significantly longer learning time as compared to their NPS counterpart (p<0.01), but this effect was prevented especially in mice supplemented with high-dose Klamin® (p<0.05) which improved performances in NPS mice (p<0.05). High-dose Klamin® supplementation restored the depleted total thiol concentration in the brain observed in PS mice while normalizing their increased malonildialdehyde level (p<0.05). Moreover, the high-dosage only caused a significant upregulation of EPO/EPOR system both in PS and in NPS animals (p<0.05). Taken together, these data suggest that this specific alga Klamath extract has considerable antioxidant and adaptogenic properties, also through a stimulatory effect of cerebral EPO/EPO system.


Subject(s)
Antioxidants/pharmacology , Brain/drug effects , Dietary Supplements , Erythropoietin/biosynthesis , Maze Learning/drug effects , Memory/drug effects , Receptors, Erythropoietin/biosynthesis , Administration, Oral , Aging/metabolism , Animals , Blotting, Western , Brain/metabolism , Brain/physiology , Erythropoietin/blood , Male , Malondialdehyde/analysis , Mice , Mice, Inbred BALB C , Models, Animal , Oxidative Stress/drug effects , Phenethylamines/pharmacology , Phycocyanin/pharmacology , Phytochrome/pharmacology , Receptors, Erythropoietin/analysis , Sulfhydryl Compounds/analysis , Up-Regulation
7.
J Biol Regul Homeost Agents ; 25(2): 221-9, 2011.
Article in English | MEDLINE | ID: mdl-21880211

ABSTRACT

There is increasing evidence that psychosocial stress can be viewed as a system-wide derangement of cellular homeostasis, with heightened oxidative stress and triggered proinflammatory mechanisms. The aim of this study is twofold: a) to replicate findings that psychological stress increases oxidative damage and b) to determine whether a fermented papaya preparation known to exert significant protective antioxidant properties could buffer such increases in nuclear DNA damage while also inducing epigenetic protective mechanisms. Twenty-eight sedentary men and women (age range: 28-52), who reported living a stressful lifestyle but with an overall positive attitude, were recruited for this study. Chronic diseases as well as severe burnout and use of drugs for anxiety constituted exclusion criteria. Subjects were supplemented for 1 month with 9 g/day (4.5 g twice a day) of a certified fermented papaya preparation. All subjects were given a stress and sleep quality questionnaire together with a diet and life style assessment. Blood was collected at 2 and 4 week, erythrocyte and leukocyte were separated to assess redox balance and heme oxygenase-1 (HO-1) gene expression while bilirubin oxidized metabolites (BOMs) were tested in the urine. Stressed individuals showed a significant abnormality of redox status with increased MDA of erythrocyte and increased level of 8-0HdG in leukocyte and BOMs excretion (p<0.05). Nutraceutical supplementation brought about a normalization of such values already at the 2 week observation (p<0.05) together with a significant upregulation of HO-1 (p<0.01). Taken together, the results of this study confirm that stressful occupational life per se, without any overt psychiatric illness, may be associated to increased oxidative stress. Supplementation with functional food affecting redox regulation may be part of the therapeutic armamentarium to be considered in this clinical setting.


Subject(s)
Antioxidants/pharmacology , Carica/chemistry , Dietary Supplements , Heme Oxygenase-1/biosynthesis , Oxidative Stress/drug effects , Plant Extracts/pharmacology , Stress, Psychological/drug therapy , 8-Hydroxy-2'-Deoxyguanosine , Adult , Antioxidants/chemistry , Antioxidants/metabolism , Bilirubin/urine , Deoxyguanosine/analogs & derivatives , Deoxyguanosine/blood , Energy Metabolism/drug effects , Energy Metabolism/physiology , Female , Fermentation , Humans , Male , Malondialdehyde/blood , Middle Aged , Oxidation-Reduction/drug effects , Oxidative Stress/physiology , Plant Extracts/chemistry , Plant Extracts/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Sedentary Behavior , Signal Transduction/drug effects , Sleep/drug effects , Sleep/physiology , Stress, Psychological/blood , Surveys and Questionnaires
8.
J Biol Regul Homeost Agents ; 24(1): 41-9, 2010.
Article in English | MEDLINE | ID: mdl-20385070

ABSTRACT

Diabetic nephropathy (DN) is a severe and life-threatening complication of long-standing diabetes. As one of the main causes of end-stage renal disease, the prevention and treatment of DN in early stage, and the slowing down of DN progression are of utmost importance and are topics of several ongoing research studies. Nutraceuticals endowed with antioxidant-anti-inflammatory properties may offer an opportunity of integrative treatment for this condition. Male Wistar rats were randomly assigned to two groups. One group of rats (diabetic group) received a single tail-vein injection of STZ compound (50 mg/kg) under light anaesthesia. A protective dose of 0.5 ml of 5 percent dextrose was given intraperitoneally 30 min before the administration of STZ. One diabetic group was fed a normal pellet diet (group A) while group B was fed the diet added with DTS (panax pseudoginseng, eucommia ulmoides), (Kyotsu Jigyo, Tokyo, Japan) in the proportion of 50/25 (percent weight/weight), at the dose of 50 mg/kg/day throughout the experimental period. At the end of 8 weeks, 24-hour urine was collected for the measurement of the albumin concentration: blood samples were collected for serum biochemistry and the rats were sacrificed for kidney measurement of oxidative stress and histomorphological features. Nephrin and Macrophage Chemoattractant Protein-1 (MCP-1) gene expression were also assessed by fluorescence real-time quantitative PCR after RNA extraction and cDNA synthesis. STZ-treated animals showed significantly increased in lipid peroxidation in the kidney and in proteinuria. DTS supplementation did not affect plasma glucose but significantly decreased malonyldialdehyde (MDA) plasma level and the overall redox parameters together with a partial mitigation of proteinuria. Histological analysis showed also that DTS significantly reduced the glomerular volume together with glomerulosclerosis and interstitial fibrosis score (p less than 0.05), the latter two being correlated to proteinuria (p less than 0.05). DTS supplementation also enabled a reduction of diabetes-induced decrease of nephrin mRNA expression and a 67 percent reduction of MCP-1 mRNA up-regulation (p less than 0.01). Taken altogether, these data show that, besides the mandatory control of glycemia, intervention with a nutraceutical with antioxidant and anti-inflammatory properties may have beneficial effects when integrated in the mainstream of the therapeutic regimen.


Subject(s)
Diabetes Mellitus, Experimental/drug therapy , Diabetic Nephropathies/prevention & control , Panax , Phytotherapy , Animals , Base Sequence , Blood Glucose/metabolism , Chemokine CCL2/genetics , DNA Primers/genetics , Diabetes Mellitus, Experimental/genetics , Diabetes Mellitus, Experimental/metabolism , Diabetes Mellitus, Experimental/pathology , Diabetic Nephropathies/genetics , Diabetic Nephropathies/metabolism , Diabetic Nephropathies/pathology , Female , Lipid Peroxidation/drug effects , Male , Membrane Proteins/genetics , Oxidative Stress/drug effects , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Rats, Wistar
9.
J Cell Biol ; 51(3): 585-95, 1971 Dec.
Article in English | MEDLINE | ID: mdl-5128349

ABSTRACT

The effect of the hormone, erythropoietin, on cultures of erythroblasts derived from the livers of fetal C57BL/6J mice was examined. An increase both in the content and in the rate of synthesis of normal adult mouse globin chains was detected in hormone-treated cultures. The rate of protein synthesis by individual erythroblasts does not increase in response to the hormone, whereas the absolute number of hemoglobin-synthesizing cells does increase and accounts for the observed stimulation of hemoglobin synthesis. The principal effect of erythropoietin appears to be upon the population of immature erythroid precursor cells which persists in the presence of the hormone, the cells maintaining their ability to replicate, and their capacity to differentiate into hemoglobinizing erythroblasts. In the absence of hormone, already committed erythroblasts continue their development, but erythropoiesis is not sustained.


Subject(s)
Erythrocytes/drug effects , Erythropoietin/pharmacology , Hemoglobins/biosynthesis , Animals , Autoradiography , Cell Count , Cell Differentiation/drug effects , Cell Division/drug effects , Chromatography , Culture Media , Culture Techniques , DNA/biosynthesis , Erythrocytes/metabolism , Erythropoiesis/drug effects , Female , Fetus , Globins/biosynthesis , Leucine/metabolism , Liver/cytology , Liver/embryology , Male , Mice , Mice, Inbred Strains , Protein Biosynthesis , Thymidine/metabolism , Time Factors , Tritium
10.
J Biol Regul Homeost Agents ; 22(4): 225-31, 2008.
Article in English | MEDLINE | ID: mdl-19036224

ABSTRACT

This study aims to determine the effects of a high protein diet and alkaline supplementation on bone metabolic turnover in rats. Eight-week-old male Sprague-Dawley rats were investigated by bone status, including bone mineral density (BMD) and biomechanical markers from blood and urine. Thirty rats were randomly divided into three groups and treated for 8 weeks as follows: baseline control group (n. 10, C), high-protein supplemented diet group (n. 10, chronic acidosis, CA group) and supplemented chronic acidosis (n.10, SCA). Diet-treated rats were fed an acidic high-protein diet and the supplementation consisted in a modified alkaline formula (Basenpulver, NaMed, Italy). At the end of the experimental period, the rats were sacrificed, blood samples were drawn and femur and tibia were removed for analysis of bone mineral density (BMD) by dual energy X-ray absorptiometry (DEXA). In the CA group, 24-hour urinary calcium (Ca) and phosphorus (P) excretion were increased 2.1-fold (p<0.05 vs normal diet controls) as well as kidney weight. However, serum Ca and P concentration, as well as urinary Dpd excretion were not significantly changed. Femural and tibial BMD was significantly decreased in the CA group (p<0.05), but alkaline supplementation prevented such phenomenon (p<0.05 vs CA). These results suggest that blood Ca and P concentrations in chronic acidosis condition during the 12-week supplementation might be maintained by hypercalciuria and hyperphosphaturia at the expenses of bone structure. However, modified alkaline supplementation is able to prevent such derangements.


Subject(s)
Alkalies/administration & dosage , Bone Remodeling/drug effects , Bone and Bones/drug effects , Bone and Bones/metabolism , Acidosis/metabolism , Alkalosis/metabolism , Animals , Biomechanical Phenomena , Bone Density/drug effects , Bone Remodeling/physiology , Calcium/blood , Dietary Proteins/administration & dosage , Dietary Supplements , Male , Phosphorus/blood , Rats , Rats, Sprague-Dawley
11.
J Clin Invest ; 68(6): 1566-76, 1981 Dec.
Article in English | MEDLINE | ID: mdl-6459341

ABSTRACT

Patients from two families with chronic hemolytic anemia have been studied. The erythrocytes are very fragile and appear microcytic with a great variety of shapes. Clinical evaluation failed to identify traditionally recognized causes of hemolysis. Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) showed no significant abnormality of the major polypeptide bands. Erythrocytes spectrin-ankyrin and ankyrin-membrane interactions were analyzed with 125I-labeled spectrin, 125I-labeled ankyrin, and inside-out vesicles. Patients' vesicles bound 125I-spectrin normally. Likewise, patients' spectrin and ankyrin competed normally for the binding sites on control membranes. None of the individual components appeared to have abnormal thermal sensitivity. Ankyrin-stripped, inside-out vesicles prepared from the patients bound less 125I-ankyrin than did vesicles prepared from normals (P less than 0.05 for all corresponding points in the high-affinity region). Scatchard analysis showed the most significant abnormality to be a 50% reduction in the high affinity ankyrin binding sites. Similar experiments were performed with blood from patients with spherocytosis and splenectomized controls, but no abnormalities were detected. The water soluble 43,000-dalton fragments of band 3 (the high-affinity ankyrin binding sites) were prepared from one of the patients and competed normally for 125I-ankyrin binding in solution. This suggests that the primary structural defect is a reduction in the number of high affinity membrane binding sites for ankyrin, and is consistent with an abnormal organization of band 3 in the membrane.


Subject(s)
Anemia, Hemolytic/blood , Cell Membrane/metabolism , Erythrocytes, Abnormal/metabolism , Membrane Proteins/metabolism , Adult , Aged , Ankyrins , Binding Sites , Binding, Competitive , Cell Membrane/analysis , Electrophoresis, Polyacrylamide Gel , Erythrocytes, Abnormal/ultrastructure , Female , Humans , Male , Microscopy, Electron, Scanning , Peptides/analysis , Protein Binding , Spectrin/metabolism , Splenectomy
12.
J Clin Invest ; 79(4): 1204-9, 1987 Apr.
Article in English | MEDLINE | ID: mdl-2881949

ABSTRACT

We have used two strategies to study 14 hemophilia B families from 11 kindreds for possible carrier detection and prenatal diagnosis. First, we sequentially used the Factor IX probes (sequentially with restriction enzymes Taq I, Xmn I, and Dde I), and the linked probes p45h (Taq I), p45d (Pst I), and 52a (Taq I) for restriction fragment length polymorphism (RFLP) analysis. Second, we searched for useful variant Taq I digestion fragments using the Factor IX complementary DNA. Two separate new Taq I variants in exon VIII were identified. Using both strategies, 11 of 14 families (from 9 of 11 kindreds) were informative for further studies. In five kindreds studied in detail, the carrier status of all 11 at risk females was determined and prenatal diagnosis could be offered to the offsprings of each of the six carriers identified. Thus, in this study, we have identified a higher proportion of informative families than has previously been reported.


Subject(s)
DNA/analysis , Deoxyribonucleases, Type II Site-Specific , Genetic Carrier Screening , Hemophilia B/genetics , DNA Restriction Enzymes/metabolism , Female , Humans , Male , Pedigree , Polymorphism, Restriction Fragment Length
13.
J Clin Invest ; 105(7): 977-84, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10841661

ABSTRACT

In multiple sclerosis (MS) patients who carry the Class II major histocompatibility (MHC) type HLA-DR2, T cells specific for amino acids 95-116 in the proteolipid protein (PLP) are activated and clonally expanded. However, it remains unclear whether these autoreactive T cells play a pathogenic role or, rather, protect against the central nervous system (CNS) damage. We have addressed this issue, using mice transgenic for the human MHC class II region carrying the HLA-DR2 (DRB1* 1502) haplotype. After stimulating cultured lymph node cells repeatedly with PLP95-116, we generated 2 HLA-DR2-restricted, PLP95-116-specific T-cell lines (TCLs) from the transgenic mice immunized with this portion of PLP. The TCLs were CD4+ and produced T-helper 1 (Th1) cytokines in response to the peptide. These TCLs were adoptively transferred into RAG-2/2 mice expressing HLA-DR2 (DRG1* 1502) molecules. Mice receiving 1 of the TCLs developed a neurological disorder manifested ataxic movement without apparent paresis on day 3, 4, or 5 after cell transfer. Histological examination revealed inflammatory foci primarily restricted to the cerebrum and cerebellum, in association with scattered demyelinating lesions in the deep cerebral cortex. These results support a pathogenic role for PLP95-116-specific T cells in HLA-DR2+ MS patients, and shed light on the possible correlation between autoimmune target epitope and disease phenotype in human CNS autoimmune diseases.


Subject(s)
Epitopes, T-Lymphocyte/immunology , HLA-DR Antigens/immunology , HLA-DR2 Antigen/immunology , Multiple Sclerosis/immunology , Myelin Proteolipid Protein/immunology , Amino Acid Sequence , Animals , DNA-Binding Proteins/genetics , DNA-Binding Proteins/immunology , Encephalomyelitis, Autoimmune, Experimental/immunology , Female , Gene Expression , HLA-DR Antigens/biosynthesis , HLA-DR Antigens/genetics , HLA-DR2 Antigen/biosynthesis , HLA-DRB1 Chains , Humans , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Mice, Transgenic , Molecular Sequence Data , Nuclear Proteins , Peptide Fragments/immunology , T-Lymphocytes, Cytotoxic/immunology
14.
Ann N Y Acad Sci ; 1089: 276-81, 2006 Nov.
Article in English | MEDLINE | ID: mdl-17261775

ABSTRACT

Ovariectomized Wistar rats received orally 15 mg/kg of a phytoestrogen compound (genistein, daidzein, glycitein, black cohosh, angelica sin., licorice, vitex agnus) for 2 weeks to test its ability to modulate inflammatory microglia response. Microglial proliferation was tested by trypan blue and by absorbance. Serial supernatant sampling was performed for 24 h to check TNF-alpha, IL-beta, IL-6, and TGF-beta. LPS caused a time course increase of all cytokines, with IL-beta and TNF-alpha peaking at the 12th hour, whereas IL-6 and TGF-beta peaked at the 24 h observation. Rats fed with the phytoestrogen displayed a significantly lower level of proinflammatory cytokines and a higher level of TGF-beta, as shown also by Western blot analysis. This finding may offer promise in the field of nutraceutical intervention.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Cytokines/metabolism , Microglia/drug effects , Neuroprotective Agents/pharmacology , Phytoestrogens/pharmacology , Animals , Cytokines/analysis , Female , Lipopolysaccharides/pharmacology , Microglia/metabolism , Rats , Rats, Wistar
15.
J Clin Pathol ; 58(10): 1110-2, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16189162

ABSTRACT

Family members in multiple generations of an Irish-American family were investigated for moderate to severe microcytic anaemia, inherited in an autosomal dominant fashion. A novel frameshift mutation of the beta globin gene was discovered. This study highlights the importance of considering dominantly inherited beta thalassemia in the investigation of anaemia, even in patients with ethnic backgrounds not usually associated with beta thalassaemia.


Subject(s)
Frameshift Mutation , Globins/genetics , beta-Thalassemia/genetics , Adult , Anemia/etiology , Anemia/genetics , Base Sequence , Child, Preschool , Female , Genes, Dominant , Humans , Middle Aged , Molecular Sequence Data , beta-Thalassemia/blood , beta-Thalassemia/complications
16.
Eur J Hum Genet ; 9(3): 217-25, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11313762

ABSTRACT

We have examined the phenotypic effects of 21 independent deletions from the fully sequenced and annotated 356 kb telomeric region of the short arm of chromosome 16 (16p13.3). Fifteen genes contained within this region have been highly conserved throughout evolution and encode proteins involved in important housekeeping functions, synthesis of haemoglobin, signalling pathways and critical developmental pathways. Although a priori many of these genes would be considered candidates for critical haploinsufficient genes, none of the deletions within the 356 kb interval cause any discernible phenotype other than alpha thalassaemia whether inherited via the maternal or paternal line. These findings contrast with previous observations on patients with larger (> 1 Mb) deletions from the 16p telomere and therefore address the mechanisms by which monosomy gives rise to human genetic disease.


Subject(s)
Chromosomes, Human, Pair 16 , Monosomy , Telomere , Adolescent , Adult , Base Sequence , Child , Child, Preschool , Female , Humans , In Situ Hybridization, Fluorescence , Male , Middle Aged , Molecular Sequence Data , Phenotype , Sequence Deletion , Sequence Homology, Nucleic Acid
17.
Gene ; 242(1-2): 337-45, 2000 Jan 25.
Article in English | MEDLINE | ID: mdl-10721728

ABSTRACT

Ermap (erythroid membrane-associated protein), a gene coding for a novel transmembrane protein produced exclusively in erythroid cells, is described. It is mapped to murine Chromosome 4, 57 cM distal to the centromere. The initial cDNA clone was isolated from a day 9 murine embryonic erythroid cell cDNA library. The predicted peptide sequence suggests that ERMAP is a transmembrane protein with two extracellular immunoglobulin folds, as well as a highly conserved B30.2 domain and several phosphorylation consensus sequences in the cytoplasmic region. ERMAP shares a high homology throughout the entire peptide with butyrophilin, a glycoprotein essential for milk lipid droplet formation and release. A GFP-ERMAP fusion protein was localized to the plasma membrane and cytoplasmic vesicles in transiently transfected 293T cells. Northern blot analysis and in-situ hybridization demonstrated that Ermap expression was restricted to fetal and adult erythroid tissues. ERMAP is likely a novel adhesion/receptor molecule specific for erythroid cells.


Subject(s)
Cell Adhesion Molecules/genetics , Erythrocytes/metabolism , Membrane Proteins/genetics , Amino Acid Sequence , Animals , Blood Group Antigens , Blotting, Northern , Butyrophilins , Cell Adhesion , Cell Line , Cell Nucleus/chemistry , Chromosome Mapping , Cloning, Molecular , Cytoplasm/chemistry , DNA, Complementary/chemistry , DNA, Complementary/genetics , Embryo, Mammalian/metabolism , Erythrocytes/cytology , Gene Expression Regulation , Gene Expression Regulation, Developmental , Green Fluorescent Proteins , Humans , In Situ Hybridization , K562 Cells , Luminescent Proteins/genetics , Luminescent Proteins/metabolism , Male , Mice , Mice, Inbred C57BL , Molecular Sequence Data , Muridae , RNA/genetics , RNA/metabolism , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Sequence Alignment , Sequence Analysis, DNA , Sequence Homology, Amino Acid , Tissue Distribution
18.
Front Biosci ; 7: a44-9, 2002 Apr 01.
Article in English | MEDLINE | ID: mdl-11897569

ABSTRACT

Abeta plays a pivotal role in the pathogenesis of Alzheimer's disease (AD), but it is still obscure how it causes AD. We have established transgenic mice carrying wild-type or familial Alzheimer's disease (FAD) mutant-type presenilin 1 (PS1). In these mice, the number of cortical and hippocampal neurons decreased along with age in mutant mice. In addition, the old mutant mice showed a significant increase of dark neurons by silver staining and the number of neurons with intracellular Abeta42 by immunohistochemistry. Our extended study also showed a significant increase of intracellular Abeta42-positive neurons in isolated cases of AD as well as in PS1 mutant FAD cases. These neurons frequently showed apoptotic staining. However, coincidence of apoptotic markers and intraneuronal neurofibrillary tangles (NFT) was insignificant. Notably intraneuronal Abeta42-labeling was frequently seen in a case of AD showing cotton-wool type senile plaques with a few NFT positive neurons and dystrophic neurites. These results indicate that intraneuronal deposition of Abeta42 is important in the pathogenesis of AD.


Subject(s)
Alzheimer Disease/metabolism , Amyloid beta-Peptides/metabolism , Peptide Fragments/metabolism , Aged , Alzheimer Disease/pathology , Amyloid beta-Peptides/immunology , Animals , Apoptosis , Brain/metabolism , Brain/pathology , Cytoplasm/metabolism , Humans , Immunohistochemistry , In Situ Nick-End Labeling , Membrane Proteins/genetics , Mice , Mice, Transgenic , Microscopy, Fluorescence , Middle Aged , Neurons/metabolism , Neurons/pathology , Peptide Fragments/immunology , Presenilin-1
19.
Psychoneuroendocrinology ; 26(5): 443-59, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11337130

ABSTRACT

Exposure to chronic stress is thought to play an important role in the etiology of depression. In this disorder, a disrupted negative feedback response to exogenous glucocorticoids on cortisol secretion has been indicated. However, the regulation of glucocorticoid negative feedback by chronic stress is not fully understood. In the present study, we investigated the effects of chronic stress administered by water immersion and restraint (2 h/day) for four weeks on the glucocorticoid feedback in rats. In the acutely (one-time) stressed rats, the basal plasma corticosterone (CORT) level was markedly elevated, remained at high levels for 5 h after the termination of stress, and then decreased. In the chronically stressed rats, the CORT level was initially elevated similarly, but rapidly decreased at 2 h. In the dexamethasone (DEX) suppression test, the peak CORT level in response to stress was not suppressed by DEX in the acutely stressed rats, but was significantly suppressed in the chronically stressed rats. In contrast, the suppressive effects of DEX on the basal CORT secretion in naive rats were attenuated in the chronically stressed rats. In the chronically stressed hippocampus, which plays an important role in the regulation of the glucocorticoid feedback response, the binding of [3H]DEX was decreased and the increased response of activator protein-1 induced by acute stress was abolished. These results suggest that chronic stress induces a hypersuppressive state for induced CORT secretion in response to acute stress, which is caused by partial habituation, coping, and adaptation to the stressor, whereas it induces a hyposuppressive state for the basal CORT secretion, which is caused by glucocorticoid receptor downregulation. These mechanisms may be involved in the stress-induced neural abnormalities observed in depression.


Subject(s)
Feedback , Glucocorticoids/pharmacology , Stress, Physiological/physiopathology , Adrenal Glands/anatomy & histology , Animals , Body Weight , Chronic Disease , Corticosterone/blood , Dexamethasone/blood , Dexamethasone/pharmacology , Down-Regulation , Glucocorticoids/blood , Hippocampus , Immersion , Kinetics , Male , Organ Size , Rats , Rats, Wistar , Receptors, Glucocorticoid , Restraint, Physical , Thymus Gland/anatomy & histology , Transcription Factor AP-1/metabolism
20.
Am J Clin Pathol ; 114(6): 927-31, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11338482

ABSTRACT

Homozygous (--SEA) alpha zero-thalassemia deletion, the cause of up to 80% of fetal hydrops in Southeast Asia, is encountered in many other countries. Heterozygous carrier rates of the deletion in Southeast Asian populations range from 4% to 14%. The laboratory screening for adult carriers of (--SEA) and other alpha zero-thalassemia deletions currently rests primarily with microscopic detection of hemoglobin H inclusion bodies within erythrocytes (Hb H screen). This test is laborious and observer dependent and has poor sensitivity. We assessed a colorimetric enzyme-linked immunosorbent assay (ELISA) to detect embryonic zeta-globin chains in adult hemolysates as an alternative to detect (--SEA) alpha zero-thalassemia deletion carriers. Blood samples from 221 adults with a mean corpuscular volume less than 80 micron 3 (80 fL) were studied prospectively by currently accepted hemoglobin screening tests and ELISA. Suspected cases of alpha-thalassemia were confirmed by DNA-based diagnostics. ELISA was highly sensitive (1.0) and specific (0.94) for the detection of adult carriers of (--SEA) alpha zero-thalassemia deletion. The hemoglobin H screen had a sensitivity of 0.47 and specificity of 0.99. The zeta-globin ELISA proved simple to perform, rapid, and applicable to high volume or population-based screening programs.


Subject(s)
Genetic Testing/methods , alpha-Thalassemia/genetics , Adult , Blood Proteins/metabolism , Enzyme-Linked Immunosorbent Assay , Gene Deletion , Genetic Testing/instrumentation , Globins/metabolism , Hemoglobin H/metabolism , Heterozygote , Humans , Reproducibility of Results , Sensitivity and Specificity , alpha-Thalassemia/blood
SELECTION OF CITATIONS
SEARCH DETAIL